1. Home
  2. PRCT

as 10-07-2025 3:29pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Medical Specialities

Nasdaq

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.

Founded: 2009 Country:
United States
United States
Employees: N/A City: SAN JOSE
Market Cap: 2.1B IPO Year: 2021
Target Price: $70.00 AVG Volume (30 days): 1.0M
Analyst Decision: Buy Number of Analysts: 8
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.56 EPS Growth: N/A
52 Week Low/High: $34.01 - $103.81 Next Earning Date: 10-27-2025
Revenue: $274,950,000 Revenue Growth: 55.71%
Revenue Growth (this year): 48.38% Revenue Growth (next year): 30.87%

Stock Insider Trading Activity of PROCEPT BioRobotics Corporation (PRCT)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
MOLL FREDERIC H PRCT N/A Aug 13 '25 Buy $39.26 20,000 $785,138.00 863,159

Share on Social Networks: